Elda Tagliabue

16.7k total citations · 1 hit paper
259 papers, 13.0k citations indexed

About

Elda Tagliabue is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elda Tagliabue has authored 259 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Oncology, 121 papers in Molecular Biology and 86 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elda Tagliabue's work include Monoclonal and Polyclonal Antibodies Research (83 papers), HER2/EGFR in Cancer Research (64 papers) and Cell Adhesion Molecules Research (39 papers). Elda Tagliabue is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (83 papers), HER2/EGFR in Cancer Research (64 papers) and Cell Adhesion Molecules Research (39 papers). Elda Tagliabue collaborates with scholars based in Italy, United States and Belgium. Elda Tagliabue's co-authors include Sylvie Ménard, Serenella M. Pupa, Manuela Campiglio, Tiziana Triulzi, Andrea Balsari, Maria I. Colnaghi, Patrizia Casalini, Lucia Sfondrini, Gabriella Sozzi and Francesca Bianchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Elda Tagliabue

252 papers receiving 12.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

2017 466 citations Chiara Camisaschi, Tiziana Triulzi et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Elda Tagliabue	6.8k	5.4k	3.3k	2.5k	2.2k	259	13.0k
Øystein Fodstad	8.1k 1.2×	5.6k 1.0×	4.5k 1.4×	2.6k 1.0×	1.1k 0.5×	307	14.8k
Sylvie Ménard	10.0k 1.5×	5.9k 1.1×	6.4k 1.9×	3.0k 1.2×	3.3k 1.5×	267	17.1k
Raffaella Giavazzi	6.2k 0.9×	4.0k 0.7×	3.4k 1.0×	1.4k 0.6×	696 0.3×	232	11.4k
Jeffrey N. Myers	6.5k 1.0×	6.5k 1.2×	2.7k 0.8×	1.2k 0.5×	920 0.4×	359	15.7k
Corazon D. Bucana	8.2k 1.2×	4.6k 0.9×	3.6k 1.1×	2.0k 0.8×	614 0.3×	145	13.9k
Gert Riethmüller	3.1k 0.5×	5.1k 0.9×	2.2k 0.7×	3.3k 1.3×	1.9k 0.9×	112	10.4k
Alexandra Giatromanolaki	7.6k 1.1×	4.2k 0.8×	5.9k 1.8×	2.0k 0.8×	1.1k 0.5×	389	15.3k
Kohzoh Imai	10.5k 1.5×	5.4k 1.0×	3.4k 1.0×	2.6k 1.0×	1.2k 0.6×	434	18.8k
Philip E. Thorpe	5.8k 0.8×	2.6k 0.5×	2.4k 0.7×	3.5k 1.4×	1.4k 0.6×	134	10.6k
Bruce R. Zetter	7.9k 1.2×	2.5k 0.5×	2.7k 0.8×	1.6k 0.7×	681 0.3×	154	13.5k

Countries citing papers authored by Elda Tagliabue

Since Specialization

Citations

This map shows the geographic impact of Elda Tagliabue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elda Tagliabue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elda Tagliabue more than expected).

Fields of papers citing papers by Elda Tagliabue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elda Tagliabue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elda Tagliabue. The network helps show where Elda Tagliabue may publish in the future.

Co-authorship network of co-authors of Elda Tagliabue

This figure shows the co-authorship network connecting the top 25 collaborators of Elda Tagliabue. A scholar is included among the top collaborators of Elda Tagliabue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elda Tagliabue. Elda Tagliabue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rybińska, Ilona, Sandra Romero‐Córdoba, Viola Regondi, et al.. (2024). SAA1‐dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness. International Journal of Cancer. 154(10). 1842–1856. 7 indexed citations

Borzi, Cristina, Claudia Moscheni, Patrizia Sartori, et al.. (2022). The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles. International Journal of Molecular Sciences. 23(24). 15802–15802. 2 indexed citations

Chiodoni, Claudia, Laura Botti, Barbara Bassani, et al.. (2022). ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation. Cancer Research. 83(1). 117–129. 9 indexed citations

Noci, Valentino Le, Giacomo Manenti, Gabriele Infante, et al.. (2022). Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model. International Journal of Molecular Sciences. 23(21). 12748–12748. 9 indexed citations

Triulzi, Tiziana, Viola Regondi, Elisabetta Venturelli, et al.. (2022). HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer. Cancers. 14(22). 5650–5650. 4 indexed citations

Bianchi, Francesca, Chiara Camisaschi, Mauro Truini, et al.. (2020). TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences. 21(4). 1440–1440. 46 indexed citations

Rybińska, Ilona, Marco Sandri, Francesca Bianchi, et al.. (2020). Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment. Cells. 9(2). 434–434. 3 indexed citations

Romero‐Córdoba, Sandra, Iván Salido-Guadarrama, María E. Meneses, et al.. (2020). Mexican Ganoderma Lucidum Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet. Nutrients. 13(1). 38–38. 18 indexed citations

Cataldo, Alessandra, Sandra Romero‐Córdoba, Ilaria Plantamura, et al.. (2020). MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer. Cancers. 12(8). 2261–2261. 18 indexed citations

10.

Romero‐Córdoba, Sandra, E. Meneghini, Milena Sant, et al.. (2019). Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation. Cancers. 11(7). 911–911. 34 indexed citations

11.

Sardi, Claudia, Barbara La Ferla, Giuseppe D’Orazio, et al.. (2014). Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis. Molecular Cancer. 13(1). 23–23. 14 indexed citations

12.

Campiglio, Manuela, Rosaria Bufalino, Elisa Ferri, et al.. (2013). Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study. Breast Cancer Research and Treatment. 141(1). 101–110. 20 indexed citations

13.

Salvi, Roberto, Serena Arima, Luca Tardella, et al.. (2013). Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD). PLoS ONE. 8(3). e58358–e58358. 9 indexed citations

14.

Sommariva, Michele, Loris De Cecco, Michelandrea De Cesare, et al.. (2011). TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects. Cancer Research. 71(20). 6382–6390. 36 indexed citations

15.

Iorio, Marilena V., Patrizia Casalini, Claudia Piovan, et al.. (2009). microRNA-205 Regulates HER3 in Human Breast Cancer. Cancer Research. 69(6). 2195–2200. 298 indexed citations

16.

Pupa, Serenella M., Fabio Castiglioni, Marco Cantù, et al.. (2007). Regulation of Breast Cancer Response to Chemotherapy by Fibulin-1. Cancer Research. 67(9). 4271–4277. 55 indexed citations

17.

Campiglio, Manuela, Yuri Pekarsky, Sylvie Ménard, et al.. (1999). FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.. PubMed. 59(16). 3866–9. 92 indexed citations

18.

Sozzi, Gabriella, Ugo Pastorino, Elda Tagliabue, et al.. (1998). Loss of FHIT function in lung cancer and preinvasive bronchial lesions.. PubMed. 58(22). 5032–7. 218 indexed citations

19.

Sozzi, Gabriella, Silvana Tornielli, Elda Tagliabue, et al.. (1997). Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.. PubMed. 57(23). 5207–12. 105 indexed citations

20.

Tagliabue, Elda, Giuliana Anna Porro, Gabriella Della Torre, et al.. (1986). Improvement of Tumor Cell Detection Using a Pool of Monoclonal Antibodies. Hybridoma. 5(2). 107–115. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact